KLRD1 and neoplasm: As reported in previous studies, the expression of peptide-loaded HLA class I molecule (HLA-E) in tumor cells can negatively mediate the anti-tumor activity of NK cell, by ligation of the NK inhibitory receptor CD94/NKG2A (KLRC1)14.